Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Nature Immunology|September 19, 2019
PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunityMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Nature Communications|April 12, 2019
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune systemMartin W LaFleur, Thao H Nguyen, Matthew A Coxe, et al.
Cancer Immunology Research|December 5, 2020
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T CellsJefte M Drijvers, Jacob E Gillis, Tara Muijlwijk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 7, 2024
In Vivo CRISPR Screening Reveals CHD7 as a Positive Regulator of Short-lived Effector CellsMartin W LaFleur, Jasmin M D'Andrea, Dillon G Patterson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2019
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockadeMohammad Rashidian, Martin W LaFleur, Vincent L Verschoor, et al.
Nature Immunology|August 12, 2025
A STUB1-CHIC2 complex inhibits CD8+ T cells to restrain tumor immunityMartin W LaFleur, Lauren E Milling, Priyamvada Prathima, et al.
Cell|June 26, 2018
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint BlockadeWanqiang Sheng, Martin W LaFleur, Thao H Nguyen, et al.
The Journal of Experimental Medicine|February 27, 2024
Framework for in vivo T cell screensLauren E Milling, Samuel C Markson, Qin Tjokrosurjo, et al.
Nature Immunology|November 27, 2023
X-CHIME enables combinatorial, inducible, lineage-specific and sequential knockout of genes in the immune systemMartin W LaFleur, Ashlyn M Lemmen, Ivy S L Streeter, et al.
Pageof 4